Loading...
ROCO
4197
Market cap8mUSD
Jul 09, Last price  
8.73TWD
1D
-3.00%
1Q
6.46%
Jan 2017
-33.05%
IPO
-71.38%
Name

Visgeneer Inc

Chart & Performance

D1W1MN
ROCO:4197 chart
P/E
50.22
P/S
1.47
EPS
0.17
Div Yield, %
Shrs. gr., 5y
0.45%
Rev. gr., 5y
0.35%
Revenues
179m
+54.68%
151,990,000175,962,000165,286,000157,964,000147,994,000115,759,000179,058,000
Net income
5m
P
-31,755,000603,000820,00012,345,000-19,589,000-17,729,0005,247,000
CFO
14m
P
-11,675,0007,567,00012,336,00043,548,00013,192,000-10,216,00014,107,000
Dividend
Jul 12, 20160.25 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Visgeneer Inc. specializes in comprehensive health and wellness solutions, with expertise spanning medical devices, cosmetics and skincare, bacterial fermentation, and cancer gene diagnostics. Its market presence covers both Europe and Asia. Within the medical device sector, the firm supplies diagnostic systems capable of monitoring vital health indicators such as blood glucose, ketones, uric acid, and cholesterol. The company boasts an extensive cosmetic and skincare portfolio, featuring diverse facial masks like wood pulp, invisible, black, pure cloth, and bio-cellulose varieties. This portfolio extends to a wide array of creams (e.g., facial, night, day, anti-wrinkle, repairing, whitening, exfoliating), alongside toners, lotions, and specialized essences. Body care offerings include lotions and therapeutic spa clay masks, complemented by sun protection solutions in physical, chemical, and broad-spectrum formulations. Cleansing agents comprise face washes, creams, mousses, gels, shampoos, and body cleansers. Further specialized products encompass hand and knee creams, foot and hand masks, glucosamine creams, anti-acne solutions, feminine hygiene lotions, general skincare products, and nutritional capsules for skin and hair. Customized skincare formulations are also part of its service. Visgeneer also promotes its distinct brands, including the eBmonitor Blood Monitoring System, CoreSence Skincare, BOWIL Skincare, and ZeaSight EU Patent Zeaxanthin. Beyond its comprehensive product lines, the company extends its expertise through contract manufacturing services. Established in 2005, Visgeneer Inc. maintains its headquarters in Hsinchu City, Taiwan.
IPO date
Oct 24, 2013
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT